Image (4ec3072f 2ab6 47ad Abf9 2aa7e5e9c112 01)
Glyburide And Metformin Hydrochloride Tablet
Product Images NDC 68382-653
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Glyburide And Metformin Hydrochloride (NDC 68382-653). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (4ec3072f 2ab6 47ad Abf9 2aa7e5e9c112 02)
This is a partial text and it appears to be a list of chemical compounds with abbreviations. The text includes the names "Metformin Hydrochloride". Based on this limited information, the text might be related to a scientific or pharmaceutical context.*
Figure (4ec3072f 2ab6 47ad Abf9 2aa7e5e9c112 03)
This is a description of a medication called Glyburide and Metformin Hydrochloride tablets, USP. Each coated tablet contains 125mg of Glyburide and 250mg of Metformin Hydrochloride. The pharmacist is instructed to disperse the patient information provided separately to each patient. This medication is available by prescription only and comes in a container of 100 tablets. The manufacturer is Cadila Healthcare L. from Badd, India and it is distributed by Zydus Pharmaceuticals USA Inc. from Pennington, New Jersey. The medication should be stored at 20°C to 25°C (68°F to 77°F) and kept out of reach of children. The complete prescribing information can be found in the package insert.*
Figure (4ec3072f 2ab6 47ad Abf9 2aa7e5e9c112 04)
This is a description of medication called Glyburide and Metformin Hydrochloride Tablets. Each tablet contains 2.5 mg of Glyburide and 500 mg of Metformin Hydrochloride. The usual dosage is stated to be described in the package insert for complete prescribing information. The medication must be stored at 20-25°C under USP Controlled Room Temperature and dispensed in a tight container. The patient information is provided separately and should be supplied to each patient. The medication is manufactured in India by Cadila Healthcare Ltd and distributed in the USA by Zydus Pharmaceuticals Inc.*
Figure (4ec3072f 2ab6 47ad Abf9 2aa7e5e9c112 05)
This is a description of a medication named Glyburide and Metformin Hydrochloride Tablets, USP, containing 5 mg/500 mg, manufactured by Cadia Healthcare Ltd in India and distributed by Zydus Pharmaceuticals USA Inc. This medication is prescribed by a doctor and dispensed by a pharmacist, with the usual dosage provided in the package insert or complete prescribing information. The medication should be stored at 20° to 25°C (68" to 77°F) and in a tight container (USP). The package comes with patient information that should be given to each patient.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
